The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intravenous Anesthetic-Global Market Insights and Sales Trends 2025
Synopsis
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
The global Intravenous Anesthetic market size is expected to reach US$ 5842.6 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous Anesthetic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Intravenous Anesthetic market. Tetrazolium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ketamine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Intravenous Anesthetic market, driven by demand from China, the second largest economy with some signs of stabilising, the Intravenous Anesthetic market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous Anesthetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous Anesthetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous Anesthetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous Anesthetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous Anesthetic covered in this report include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc.
The global Intravenous Anesthetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Global Intravenous Anesthetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous Anesthetic market, Segment by Type:
Tetrazolium
Ketamine
Other
Global Intravenous Anesthetic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
The global Intravenous Anesthetic market size is expected to reach US$ 5842.6 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous Anesthetic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Intravenous Anesthetic market. Tetrazolium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ketamine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Intravenous Anesthetic market, driven by demand from China, the second largest economy with some signs of stabilising, the Intravenous Anesthetic market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous Anesthetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous Anesthetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous Anesthetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous Anesthetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous Anesthetic covered in this report include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc.
The global Intravenous Anesthetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Global Intravenous Anesthetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous Anesthetic market, Segment by Type:
Tetrazolium
Ketamine
Other
Global Intravenous Anesthetic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Intravenous Anesthetic Market Overview
1.1 Intravenous Anesthetic Product Overview
1.2 Intravenous Anesthetic Market Segment by Type
1.2.1 Tetrazolium
1.2.2 Ketamine
1.2.3 Other
1.3 Global Intravenous Anesthetic Market Size by Type
1.3.1 Global Intravenous Anesthetic Market Size Overview by Type (2018-2029)
1.3.2 Global Intravenous Anesthetic Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intravenous Anesthetic Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intravenous Anesthetic Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intravenous Anesthetic Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intravenous Anesthetic Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intravenous Anesthetic Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intravenous Anesthetic Sales Breakdown by Type (2018-2023)
2 Global Intravenous Anesthetic Market Competition by Company
2.1 Global Top Players by Intravenous Anesthetic Sales (2018-2023)
2.2 Global Top Players by Intravenous Anesthetic Revenue (2018-2023)
2.3 Global Top Players by Intravenous Anesthetic Price (2018-2023)
2.4 Global Top Manufacturers Intravenous Anesthetic Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous Anesthetic Market Competitive Situation and Trends
2.5.1 Intravenous Anesthetic Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravenous Anesthetic Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Anesthetic as of 2022)
2.7 Date of Key Manufacturers Enter into Intravenous Anesthetic Market
2.8 Key Manufacturers Intravenous Anesthetic Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravenous Anesthetic Status and Outlook by Region
3.1 Global Intravenous Anesthetic Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intravenous Anesthetic Historic Market Size by Region
3.2.1 Global Intravenous Anesthetic Sales in Volume by Region (2018-2023)
3.2.2 Global Intravenous Anesthetic Sales in Value by Region (2018-2023)
3.2.3 Global Intravenous Anesthetic Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intravenous Anesthetic Forecasted Market Size by Region
3.3.1 Global Intravenous Anesthetic Sales in Volume by Region (2024-2029)
3.3.2 Global Intravenous Anesthetic Sales in Value by Region (2024-2029)
3.3.3 Global Intravenous Anesthetic Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intravenous Anesthetic by Application
4.1 Intravenous Anesthetic Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Intravenous Anesthetic Market Size by Application
4.2.1 Global Intravenous Anesthetic Market Size Overview by Application (2018-2029)
4.2.2 Global Intravenous Anesthetic Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intravenous Anesthetic Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intravenous Anesthetic Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intravenous Anesthetic Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intravenous Anesthetic Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intravenous Anesthetic Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intravenous Anesthetic Sales Breakdown by Application (2018-2023)
5 North America Intravenous Anesthetic by Country
5.1 North America Intravenous Anesthetic Historic Market Size by Country
5.1.1 North America Intravenous Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intravenous Anesthetic Sales in Volume by Country (2018-2023)
5.1.3 North America Intravenous Anesthetic Sales in Value by Country (2018-2023)
5.2 North America Intravenous Anesthetic Forecasted Market Size by Country
5.2.1 North America Intravenous Anesthetic Sales in Volume by Country (2024-2029)
5.2.2 North America Intravenous Anesthetic Sales in Value by Country (2024-2029)
6 Europe Intravenous Anesthetic by Country
6.1 Europe Intravenous Anesthetic Historic Market Size by Country
6.1.1 Europe Intravenous Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intravenous Anesthetic Sales in Volume by Country (2018-2023)
6.1.3 Europe Intravenous Anesthetic Sales in Value by Country (2018-2023)
6.2 Europe Intravenous Anesthetic Forecasted Market Size by Country
6.2.1 Europe Intravenous Anesthetic Sales in Volume by Country (2024-2029)
6.2.2 Europe Intravenous Anesthetic Sales in Value by Country (2024-2029)
7 Asia-Pacific Intravenous Anesthetic by Region
7.1 Asia-Pacific Intravenous Anesthetic Historic Market Size by Region
7.1.1 Asia-Pacific Intravenous Anesthetic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intravenous Anesthetic Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intravenous Anesthetic Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intravenous Anesthetic Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravenous Anesthetic Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intravenous Anesthetic Sales in Value by Region (2024-2029)
8 Latin America Intravenous Anesthetic by Country
8.1 Latin America Intravenous Anesthetic Historic Market Size by Country
8.1.1 Latin America Intravenous Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intravenous Anesthetic Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intravenous Anesthetic Sales in Value by Country (2018-2023)
8.2 Latin America Intravenous Anesthetic Forecasted Market Size by Country
8.2.1 Latin America Intravenous Anesthetic Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intravenous Anesthetic Sales in Value by Country (2024-2029)
9 Middle East and Africa Intravenous Anesthetic by Country
9.1 Middle East and Africa Intravenous Anesthetic Historic Market Size by Country
9.1.1 Middle East and Africa Intravenous Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intravenous Anesthetic Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intravenous Anesthetic Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intravenous Anesthetic Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravenous Anesthetic Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intravenous Anesthetic Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Intravenous Anesthetic Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Fresenius-Kabi
10.2.1 Fresenius-Kabi Company Information
10.2.2 Fresenius-Kabi Introduction and Business Overview
10.2.3 Fresenius-Kabi Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius-Kabi Intravenous Anesthetic Products Offered
10.2.5 Fresenius-Kabi Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Information
10.3.2 AbbVie Introduction and Business Overview
10.3.3 AbbVie Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AbbVie Intravenous Anesthetic Products Offered
10.3.5 AbbVie Recent Development
10.4 Baxter Healthcare
10.4.1 Baxter Healthcare Company Information
10.4.2 Baxter Healthcare Introduction and Business Overview
10.4.3 Baxter Healthcare Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter Healthcare Intravenous Anesthetic Products Offered
10.4.5 Baxter Healthcare Recent Development
10.5 B.Braun
10.5.1 B.Braun Company Information
10.5.2 B.Braun Introduction and Business Overview
10.5.3 B.Braun Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B.Braun Intravenous Anesthetic Products Offered
10.5.5 B.Braun Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mylan Intravenous Anesthetic Products Offered
10.6.5 Mylan Recent Development
10.7 Hengrui
10.7.1 Hengrui Company Information
10.7.2 Hengrui Introduction and Business Overview
10.7.3 Hengrui Intravenous Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hengrui Intravenous Anesthetic Products Offered
10.7.5 Hengrui Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravenous Anesthetic Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravenous Anesthetic Industrial Chain Analysis
11.4 Intravenous Anesthetic Market Dynamics
11.4.1 Intravenous Anesthetic Industry Trends
11.4.2 Intravenous Anesthetic Market Drivers
11.4.3 Intravenous Anesthetic Market Challenges
11.4.4 Intravenous Anesthetic Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravenous Anesthetic Distributors
12.3 Intravenous Anesthetic Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
